Asset Management One Co. Ltd. lessened its holdings in Cigna Group (NYSE:CI – Free Report) by 2.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 112,977 shares of the health services provider’s stock after selling 2,378 shares during the period. Asset Management One Co. Ltd.’s holdings in Cigna Group were worth $37,348,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Valeo Financial Advisors LLC increased its position in Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares in the last quarter. Nuveen LLC acquired a new stake in Cigna Group in the first quarter valued at approximately $727,905,000. Price T Rowe Associates Inc. MD grew its stake in shares of Cigna Group by 10.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after buying an additional 1,094,327 shares during the last quarter. GQG Partners LLC grew its stake in shares of Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after buying an additional 865,092 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its holdings in shares of Cigna Group by 38.3% during the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after buying an additional 457,052 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.
Insider Buying and Selling at Cigna Group
In other news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the sale, the insider owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company’s stock.
Cigna Group Trading Down 1.1%
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. During the same period in the prior year, the company posted $6.72 EPS. The company’s revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts forecast that Cigna Group will post 29.77 EPS for the current year.
Cigna Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a dividend of $1.51 per share. The ex-dividend date is Thursday, December 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. Cigna Group’s dividend payout ratio is 32.97%.
Analysts Set New Price Targets
Several research firms recently weighed in on CI. Barclays raised their price objective on Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Deutsche Bank Aktiengesellschaft set a $415.00 price target on Cigna Group and gave the stock a “buy” rating in a report on Tuesday, August 5th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $365.00 price objective on shares of Cigna Group in a report on Tuesday, August 26th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Cigna Group in a research report on Friday. Finally, Robert W. Baird set a $372.00 price target on shares of Cigna Group in a research report on Thursday, August 14th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and an average price target of $369.89.
Check Out Our Latest Report on Cigna Group
Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories
- Five stocks we like better than Cigna Group
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- CD Calculator: Certificate of Deposit Calculator
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- Investing In Preferred Stock vs. Common Stock
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
